Desmoteplase moves forward for stroke in Japan
This article was originally published in Scrip
Executive Summary
Lundbeck's candidate for the treatment of acute ischaemic stroke, desmoteplase, has moved into Phase II development in Japan, marking the first time for the Danish group to directly conduct a clinical trial in the country.